Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.
Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors - Implications for dose-sparing combination therapies.
The possible effects of the solar and geomagnetic activity on multiple sclerosis.
Keystone Symposium: T Cells: Regulation and Effector Function
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
Differences in the burden of psychiatric comorbidity in MS vs the general population.
Optical Coherence Tomography in Multiple Sclerosis.
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.
MicroRNAs: The Role in Autoimmune Inflammation.
10 years of interferon beta-1b (Beta feron therapy.
New data reinforce efficacy of TECFIDERA® (dimethyl fumarate) in MS patients with high disease activity
Tizanidine: Can Buy Uk
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis.
Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
ForuMS: A Virtual Journal Club for MS Clinicians
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
Episode 28 with Dr. Brenda Banwell on pediatric MS
The "poison chair" treatment for multiple sclerosis.
Intrathecal interferon reduces exacerbations of multiple sclerosis.
Multiple Sclerosis Society Education Conference
The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids.
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Full Prescribing Information, Copaxone (glatiramer acetate)
Pages
« first
‹ previous
…
68
69
70
71
72
73
74
75
76
…
next ›
last »